- Home
- ELLO vs NKTR Comparison
ELLO vs NKTR Comparison
Compare ELLO & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELLO
- NKTR
- Stock Information
- Founded
- ELLO 1987
- NKTR 1990
- Country
- ELLO Israel
- NKTR United States
- Employees
- ELLO N/A
- NKTR N/A
- Industry
- ELLO Electric Utilities: Central
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- ELLO Utilities
- NKTR Health Care
- Exchange
- ELLO Nasdaq
- NKTR Nasdaq
- Market Cap
- ELLO 208.2M
- NKTR 247.9M
- IPO Year
- ELLO 1995
- NKTR 1994
- Fundamental
- Price
- ELLO $15.60
- NKTR $0.93
- Analyst Decision
- ELLO
- NKTR Strong Buy
- Analyst Count
- ELLO 0
- NKTR 5
- Target Price
- ELLO N/A
- NKTR $4.50
- AVG Volume (30 Days)
- ELLO 1.7K
- NKTR 3.0M
- Earning Date
- ELLO 03-31-2025
- NKTR 03-03-2025
- Dividend Yield
- ELLO N/A
- NKTR N/A
- EPS Growth
- ELLO N/A
- NKTR N/A
- EPS
- ELLO N/A
- NKTR N/A
- Revenue
- ELLO $44,850,546.00
- NKTR $93,137,000.00
- Revenue This Year
- ELLO N/A
- NKTR $12.15
- Revenue Next Year
- ELLO N/A
- NKTR N/A
- P/E Ratio
- ELLO N/A
- NKTR N/A
- Revenue Growth
- ELLO N/A
- NKTR 5.53
- 52 Week Low
- ELLO $11.08
- NKTR $0.63
- 52 Week High
- ELLO $20.81
- NKTR $1.93
- Technical
- Relative Strength Index (RSI)
- ELLO 46.16
- NKTR 53.83
- Support Level
- ELLO $15.10
- NKTR $0.92
- Resistance Level
- ELLO $16.91
- NKTR $1.08
- Average True Range (ATR)
- ELLO 0.76
- NKTR 0.09
- MACD
- ELLO -0.01
- NKTR 0.03
- Stochastic Oscillator
- ELLO 43.29
- NKTR 65.63
About ELLO Ellomay Capital Ltd (Israel)
Ellomay Capital Ltd is focused on the utility sector. It is an Israeli public company, which focuses its business in the energy and infrastructure sectors. The company's operating segment includes Photovoltaic power plants (PV Plants); Dorad Energy Ltd. (Dorad); Groen Gas Goor B.V. and a Pumped storage hydro power plant (Manara). It generates maximum revenue from the Dorad segment. Geographically, it derives a majority of its revenue from Spain.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.